MUMBAI, India, Sept. 22 -- Intellectual Property India has published a patent application (202617071127 A) filed by Seaport Therapeutics, Inc. on June 08, 2026, for Lipid Prodrugs Of Allopregnanolone And Uses Thereof.
Inventors include Chen, Michael C.; Bonner, Daniel Kenneth; Shipley, James E.; Schnee, Janet M.; and Elenko, Eric.
The application for the patent was published on September 18, 2026, under issue no. 38/2026.
Abstract: Disclosed herein are methods of treating a subject in need thereof with an orally-administered lipid prodrug of allopregnanolone. The methods described herein may be used for the treatment of major depressive disorder (MDD) with anxious distress or major depressive disorder (MDD) without anxious distress.
Disclaimer: Curated by HT Syndication.
